论文部分内容阅读
意大利米兰讯—意大利和挪威的研究人员报道:处在乳腺癌高危险性的健康妇女,若服用1/4量的常规20mg日剂量的它莫西芬(tamoxifen),便有可能获得相同的抗乳腺癌产生的保护作用。在米兰欧洲肿瘤研究所化学预防室工作
MILAN, ITALY - Researchers from Italy and Norway report that in healthy women at high risk of breast cancer, the same level of resistance is likely to be achieved by taking 1/4 of a tamoxifen of the usual 20 mg daily dose Breast cancer protective effect. Worked at the Chemical Preventive Laboratory at the European Institute of Oncology in Milan